Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

175 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The effect of treatment intensification in HIV-infection: a study comparing treatment with ritonavir/saquinavir and ritonavir/saquinavir/stavudine. Prometheus Study Group.
Gisolf EH, Jurriaans S, Pelgrom J, van Wanzeele F, van der Ende ME, Brinkman K, Borst MJ, de Wolf F, Japour AJ, Danner SA. Gisolf EH, et al. Among authors: van wanzeele f, van der ende me. AIDS. 2000 Mar 10;14(4):405-13. doi: 10.1097/00002030-200003100-00014. AIDS. 2000. PMID: 10770543 Clinical Trial.
Zidovudine and interferon-alpha combination therapy versus zidovudine monotherapy in subjects with symptomatic human immunodeficiency virus type 1 infection.
Frissen PH, van der Ende ME, ten Napel CH, Weigel HM, Schreij GS, Kauffmann RH, Koopmans PP, Hoepelman AI, de Boer JB, Weverling GJ, et al. Frissen PH, et al. Among authors: van der ende me. J Infect Dis. 1994 Jun;169(6):1351-5. doi: 10.1093/infdis/169.6.1351. J Infect Dis. 1994. PMID: 7910838 Clinical Trial.
Immune restoration does not invariably occur following long-term HIV-1 suppression during antiretroviral therapy. INCAS Study Group.
Pakker NG, Kroon ED, Roos MT, Otto SA, Hall D, Wit FW, Hamann D, van der Ende ME, Claessen FA, Kauffmann RH, Koopmans PP, Kroon FP, ten Napel CH, Sprenger HG, Weigel HM, Montaner JS, Lange JM, Reiss P, Schellekens PT, Miedema F. Pakker NG, et al. Among authors: van der ende me. AIDS. 1999 Feb 4;13(2):203-12. doi: 10.1097/00002030-199902040-00008. AIDS. 1999. PMID: 10202826
A phase II safety and efficacy study of amprenavir in combination with zidovudine and lamivudine in HIV-infected patients with limited antiretroviral experience. Amprenavir PROAB2002 Study Team.
Haubrich R, Thompson M, Schooley R, Lang W, Stein A, Sereni D, van der Ende ME, Antunes F, Richman D, Pagano G, Kahl L, Fetter A, Brown DJ, Clumeck N. Haubrich R, et al. Among authors: van der ende me. AIDS. 1999 Dec 3;13(17):2411-20. doi: 10.1097/00002030-199912030-00013. AIDS. 1999. PMID: 10597783 Clinical Trial.
Once-daily indinavir plus ritonavir: preliminary results of the PIPO study.
Burger DM, Hugen PW, van der Ende ME, van Wijngaarden P, Aarnoutse RE, Reiss P, Lange JM. Burger DM, et al. Among authors: van der ende me, van wijngaarden p. AIDS. 2000 Nov 10;14(16):2621-3. doi: 10.1097/00002030-200011100-00032. AIDS. 2000. PMID: 11101081 Clinical Trial. No abstract available.
A dose-ranging study to evaluate the antiretroviral activity and safety of amprenavir alone and in combination with abacavir in HIV-infected adults with limited antiretroviral experience.
Schooley RT, Clumeck N, Haubrich R, Thompson M, Danner SA, van Der Ende ME, Sereni D, Antunes F, Blake D, Myers RE, Tisdale M, Millard J, Mustafa N, Nacci P. Schooley RT, et al. Among authors: van der ende me. Antivir Ther. 2001 Jun;6(2):89-96. Antivir Ther. 2001. PMID: 11491421 Clinical Trial.
175 results